{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:54:25Z","timestamp":1770728065381,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.taap.2022.116134","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T21:40:58Z","timestamp":1655502058000},"page":"116134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4)"],"prefix":"10.1016","volume":"449","author":[{"given":"Yao-Yu","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.116134_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172784","article-title":"Old wine in new bottles: drug repurposing in oncology","volume":"866","author":"Antoszczak","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2022.116134_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2016.09.012","article-title":"The role of S100a4 (Mts1) in Apc- and Smad4-driven tumour onset and progression","volume":"68","author":"Atlasi","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2022.116134_bb0015","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1038\/sj.bjc.6604642","article-title":"Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells","volume":"99","author":"Benhadji","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2022.116134_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3967","article-title":"An ecosystem of cancer cell line factories to support a cancer dependency map","volume":"16","author":"Boehm","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.taap.2022.116134_bb0025","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.3748\/wjg.v11.i31.4852","article-title":"Overexpression of S100A4 is closely associated with progression of colorectal cancer","volume":"11","author":"Cho","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2022.116134_bb0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.det.2019.05.003","article-title":"Nonsurgical treatments for nonmelanoma skin Cancer","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.taap.2022.116134_bb0035","doi-asserted-by":"crossref","first-page":"783","DOI":"10.18632\/oncotarget.572","article-title":"Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation","volume":"3","author":"Dahlmann","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2022.116134_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8060059","article-title":"S100A4 in Cancer metastasis: Wnt signaling-driven interventions for metastasis restriction","volume":"8","author":"Dahlmann","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2022.116134_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2022.116134_bb0050","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1021\/bi200853y","article-title":"Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA","volume":"50","author":"Dulyaninova","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.taap.2022.116134_bb0055","first-page":"1","article-title":"Ingenol mebutate: an introduction","volume":"17","author":"Fallen","year":"2012","journal-title":"Skin Therapy Lett."},{"key":"10.1016\/j.taap.2022.116134_bb0060","doi-asserted-by":"crossref","first-page":"73219","DOI":"10.18632\/oncotarget.18016","article-title":"S100A4 in cancer progression and metastasis: a systematic review","volume":"8","author":"Fei","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.taap.2022.116134_bb0065","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1535-7163.MCT-15-0023-T","article-title":"Ingenol Mebutate signals via PKC\/MEK\/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2","volume":"14","author":"Freiberger","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2022.116134_bb0070","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1158\/0008-5472.CAN-08-2837","article-title":"Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells","volume":"69","author":"Ghoul","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2022.116134_bb0075","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1053\/gast.2002.36606","article-title":"Prognostic significance of calcium-binding protein S100A4 in colorectal cancer","volume":"123","author":"Gongoll","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2022.116134_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058540","article-title":"Protein kinase C delta negatively modulates canonical Wnt pathway and cell proliferation in colon tumor cell lines","volume":"8","author":"Hernandez-Maqueda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2022.116134_bb0085","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1158\/1078-0432.CCR-09-1431","article-title":"Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal Cancer","volume":"15","author":"Jorissen","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2022.116134_bb0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.36849\/JDD.2020.4731","article-title":"Ingenol Mebutate: expanded utility","volume":"19","author":"Khalfe","year":"2020","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.taap.2022.116134_bb0095","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"366","author":"Lebwohl","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2022.116134_bb0100","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1746-1596-8-181","article-title":"Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.taap.2022.116134_bb0105","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1074\/jbc.RA118.004365","article-title":"S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2","volume":"294","author":"Liu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2022.116134_bb0110","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1073\/pnas.0913660107","article-title":"Phenothiazines inhibit S100A4 function by inducing protein oligomerization","volume":"107","author":"Malashkevich","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2022.116134_bb0115","first-page":"18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes","volume":"2","author":"Mizuno","year":"2009","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.taap.2022.116134_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.taap.2022.116134_bb0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbcan.2019.04.005","article-title":"Drug repurposing in oncology: compounds, pathways, phenotypes and computational approaches for colorectal cancer","volume":"1871","author":"Nowak-Sliwinska","year":"2019","journal-title":"Biochim. Biophys. Acta-Rev. Cancer"},{"key":"10.1016\/j.taap.2022.116134_bb0130","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1074\/mcp.M700202-MCP200","article-title":"Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling","volume":"6","author":"Orre","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.taap.2022.116134_bb0135","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/onc.2013.213","article-title":"S100A4 interacts with p53 in the nucleus and promotes p53 degradation","volume":"32","author":"Orre","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.taap.2022.116134_bb0140","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1091\/mbc.e10-09-0739","article-title":"S100A4-induced cell motility and metastasis is restricted by the Wnt\/beta-catenin pathway inhibitor calcimycin in colon cancer cells","volume":"22","author":"Sack","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.taap.2022.116134_bb0145","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jnci\/djr190","article-title":"Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer","volume":"103","author":"Sack","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2022.116134_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120553","article-title":"Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment","volume":"601","author":"Shen","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2022.116134_bb0155","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.taap.2022.116134_bb0160","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2009.11.005","article-title":"Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer","volume":"138","author":"Smith","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2022.116134_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00109-009-0467-y","article-title":"An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types","volume":"87","author":"Staub","year":"2009","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.taap.2022.116134_bb0170","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2022.116134_bb0175","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.taap.2022.116134_bb0180","first-page":"2309","article-title":"Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas","volume":"3","author":"Takenaga","year":"1997","journal-title":"Clin. Cancer Res."},{"issue":"564\u2013576","key":"10.1016\/j.taap.2022.116134_bb0185","article-title":"Defining a cancer dependency map","volume":"170","author":"Tsherniak","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.taap.2022.116134_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121932","article-title":"Promising colorectal cancer biomarkers for precision prevention and therapy","volume":"11","author":"Turano","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2022.116134_bb0195","article-title":"Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Mater. Today Biol."},{"key":"10.1016\/j.taap.2022.116134_bb0200","article-title":"S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis","volume":"7","author":"Zhang","year":"2018","journal-title":"Oncoimmunology"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:02:19Z","timestamp":1758574939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"alternative-id":["S0041008X22002794"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.116134","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4)","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.116134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116134"}}